EDITORIAL
Published on 25 Aug 2022
Editorial: Interventional therapy of hepatocellular carcinoma
doi 10.3389/fmolb.2022.972207
- 1,187 views
- Frontiers in Molecular Biosciences
- Molecular Diagnostics and Therapeutics
- Research Topics
- Interventional Therapy of Hepatocellular Carcinoma
Interventional Therapy of Hepatocellular Carcinoma
17k
Total downloads
45k
Total views and downloads
Articles
CORRECTION
Published on 03 Aug 2022
Corrigendum: Purified PTEN-Long induces liver cancer cells to undergo autophagy and apoptosis
doi 10.3389/fsurg.2022.982545
- 1,590 views
ORIGINAL RESEARCH
Published on 11 May 2022
Purified PTEN-Long Induces Liver Cancer Cells to Undergo Autophagy and Apoptosis
doi 10.3389/fsurg.2022.767611
- 1,997 views
- 4 citations
ORIGINAL RESEARCH
Published on 28 Oct 2021
Superselective Transarterial Chemoembolization for Unresectable or “Ablation Unsuitable” Hepatocellular Carcinoma in the Caudate Lobe: A Real World, Single-Center Retrospective Study
doi 10.3389/fonc.2021.678847
- 1,815 views
- 4 citations
ORIGINAL RESEARCH
Published on 27 Oct 2021
Hepatic Resection Versus Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: A Cohort Study
doi 10.3389/fonc.2021.618937
- 2,020 views
- 23 citations
ORIGINAL RESEARCH
Published on 31 Aug 2021
A Radiomics Signature-Based Nomogram to Predict the Progression-Free Survival of Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation
doi 10.3389/fmolb.2021.662366
- 3,003 views
- 9 citations
CORRECTION
Published on 30 Aug 2021
Corrigendum: Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Outcomes in Patients With Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Plus Sorafenib
doi 10.3389/fmolb.2021.727969
- 931 views
ORIGINAL RESEARCH
Published on 07 Jul 2021
Efficacy and Safety of Transarterial Chemoembolization in Elderly Patients of Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Retrospective Study
doi 10.3389/fonc.2021.646410
- 1,756 views
- 8 citations
ORIGINAL RESEARCH
Published on 28 May 2021
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Outcomes in Patients With Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Plus Sorafenib
doi 10.3389/fmolb.2021.624366
- 2,287 views
- 12 citations
ORIGINAL RESEARCH
Published on 20 May 2021
Random Survival Forests to Predict Disease Control for Hepatocellular Carcinoma Treated With Transarterial Chemoembolization Combined With Sorafenib
doi 10.3389/fmolb.2021.618050
- 2,011 views
- 8 citations
ORIGINAL RESEARCH
Published on 26 Mar 2021
Development of TACE Refractoriness Scores in Hepatocellular Carcinoma
doi 10.3389/fmolb.2021.615133
- 4,976 views
- 11 citations
ORIGINAL RESEARCH
Published on 18 Mar 2021
Development and Validation of a Predictive Model for Early Refractoriness of Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma
doi 10.3389/fmolb.2021.633590
- 2,237 views
- 11 citations
Published in
Frontiers in Molecular Biosciences
Molecular Diagnostics and Therapeutics
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Frontiers in Surgery
- 1.6 impact factor
- 1.9 citescore